Botanical species · safety record

Sprekelia formosissima

The EFSA Compendium of Botanicals holds 7 constituent measurements for Sprekelia formosissima. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Sprekelia formosissima (L.) Herb.

7Constituent measurements
0Safety records
3Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids3
  • Daidzein1
  • Glycitin1
  • Haemanthamine1
  • Tazettine1

Plant parts

  • Bulb7
  • clove7

Preparations

  • Solvent extraction7

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsBulb / cloveSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsBulb / cloveSolvent extractionGC-MSNo resolvable identifier
AlkaloidsBulb / cloveSolvent extractionGC-MSNo resolvable identifier
DaidzeinBulb / cloveSolvent extraction44.6 Gram/100 gramHPLC-MS/MSNo resolvable identifier
GlycitinBulb / cloveSolvent extraction51.6 Gram/100 gramHPLC-MS/MSNo resolvable identifier
HaemanthamineBulb / cloveSolvent extraction54 PercentGC-MSNo resolvable identifier
TazettineBulb / cloveSolvent extraction45 PercentGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Cahlikova, Lucie., Benesova, Nina., Macakova, Katerina., Urbanova, Klara., Opletal, Lubomir. GC/MS Analysis of Three Amaryllidaceae Species and Their Cholinesterase Activity . Natural product communications, 2011, vol. 6, no. 9, p. 1255-1258.
  2. Miksatkova, Petra., Lankova, Petra., Huml, Lukas., Lapcik, Oldrich. Isoflavonoids in the Amaryllidaceae family. Natural product research, 2014, vol. 28, no. 10, p. 690-697.
  3. Hohmann, J., Forgo, P., Molnar, J., Wolfard, K., Molnar, A., Thalhammer, T., Mathe, I., Sharples, D. Antiproliferative Amaryllidaceae alkaloids isolated from the bulbs of Sprekelia formosissima and Hymenocallis x festalis . Planta medica, 2002, vol. 68, no. 5, p. 454-457. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue